tiprankstipranks
Trending News
More News >

Sino Biopharmaceutical Proposes Amendments to Articles of Association

Story Highlights
Sino Biopharmaceutical Proposes Amendments to Articles of Association

Confident Investing Starts Here:

An update from Sino Biopharmaceutical ( (HK:1177) ) is now available.

Sino Biopharmaceutical Limited’s board of directors has proposed the adoption of amended and restated articles of association to align with recent changes in the Hong Kong Stock Exchange’s Listing Rules, including the expansion of the paperless listing regime and the treasury shares regime. The proposed amendments aim to enhance clarity and make consequential changes, pending shareholder approval at the upcoming annual general meeting.

More about Sino Biopharmaceutical

Sino Biopharmaceutical Limited is a company incorporated in the Cayman Islands, operating in the biopharmaceutical industry. It focuses on the development, manufacturing, and sale of pharmaceutical products, primarily targeting the healthcare market.

YTD Price Performance: 20.0%

Average Trading Volume: 2,321

Technical Sentiment Signal: Sell

Current Market Cap: $8.84B

Learn more about 1177 stock on TipRanks’ Stock Analysis page.

Disclaimer & Disclosure

Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.

Report an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App